Goldiam International Q2 FY26 Concall Decoded: “Tariffs, Lab-Grown Diamonds & the U.S. Casting Plot Twist”
1. Opening Hook
When the U.S. hiked tariffs from 16% to a blistering 56%, most Indian jewellers gasped. Goldiam? They simply said, “Hold my diamond” and started casting gold in America. Because why dodge duties when you can redesign the supply chain? 🇺🇸💍 The lab-grown segment might be polarizing critics, but Goldiam’s numbers are pure sparkle — 43% revenue growth, 42% PAT jump, and a B2C baby called ORIGEM that’s flexing its new stores like they’re red-carpet events. Keep reading — the “lab-grown vs natural” war is getting juicy, and Goldiam’s playing both the craftsman and the disruptor.
2. At a Glance
Revenue up 43%: Tariffs couldn’t dull this shine — they just made it more creative.
EBITDA up 37%: Margins steady at 21.6% — premium polish maintained.
PAT up 42%: Profit sparkled brighter than last quarter’s diamond necklace.
Order Book ₹200 Cr: Santa’s orders are already in.
Lab-Grown share 90%: Nature who? Synthetic is the new organic.
Online revenue 20%: Clicks over carats are officially a thing.
Inventory up: U.S. casting = more gold chilling in warehouses than in vaults.
3. Management’s Key Commentary
“Tariffs shot up to 56%, but we responded with a U.S.-origin casting model.” (Translation: When in doubt, cast in America and call it strategy. 🇺🇸)
“Revenue grew 43%, PAT by 42%, and margins held firm.” (Translation: Even Uncle Sam’s tax man couldn’t scratch our shine.)
“Lab-grown jewellery contributes 90% to B2B sales.” (Translation: Nature’s out, nitrogen’s in — diamonds are now brewed, not mined.)
“ORIGEM now has 11 stores; expect 25 by March 2026.” (Translation: Retail therapy, but in carats per square foot. 💎)
“We raised ₹202 Cr via QIP for ORIGEM’s expansion.” (Translation: Investors are funding our sparkle addiction.)
“Casting in the U.S. adds cost but improves gross margins.” (Translation: Paying Americans to dodge their own tariffs — genius! 😏)
“Lab-grown prices are rising 5–11% for smaller stones.” (Translation: Turns out artificial scarcity works even for artificial diamonds.)
4. Numbers Decoded
Metric
Q2 FY26
Q2 FY25
YoY Change
Commentary
Revenue (₹ Cr)
+43%
Lab-grown rush and U.S. model magic.
EBITDA Margin
21.6%
21.3%
Stable
Smooth as polished platinum.
PAT Growth
+42%
–
Strong
No tariff tantrums here.
Online Revenue Share
20%
14%
Rising
Millennials swipe for sparkle.
Lab-Grown Share
90%
70%
+20 pts
Natural diamonds crying quietly.
Order Book
₹200 Cr
₹180 Cr
+11%
Holiday season locked in.
ORIGEM Revenue
₹2.8 Cr
₹3.2 Cr (Q1)
-12%
Pre-Diwali lull, post-Diwali bling.
💰 Margins glitter, but working capital’s turning into a gold mine — literally, stuck as inventory.
5. Analyst Questions
Q: Is lab-grown demand peaking in the U.S.? A: “Still early innings; 30-35% of retailer sales are lab-grown.” (Translation: There’s still room to grow — and glow.)
Q: Why the ORIGEM dip this quarter? A: “Festive sales shifted to October.” (Translation: India buys jewellery only when there’s a puja or a selfie involved.)
Q: How will tariffs affect dot-com sales? A: “Slight delay, but no slowdown.” (Translation: We’ll deliver your diamond in 10 days instead of 6 — relax.)
Q: Who’s buying at ORIGEM? A: “Mid-30s to 50s, not just Gen Z.” (Translation: Even aunties love affordable sparkle.)
Q: China competition? A: “They cut smaller diamonds. We cut the noise.” (Translation: Let them polish drills, we’ll polish rings.)
6. Guidance & Outlook
Management stays cautiously bullish: B2B to grow at double digits CAGR
